Izmir Dr. Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit
Izmir, Yenisehir, 35550, Turkey (Türkiye)
NCT Number: NCT04089111
This study evaluates the safety and efficacy of high tidal volumes generated by "Adapted Support Ventilation (ASV) mode' in mechanically ventilated severe COPD patients. Every patient will be ventilated consecutively with ASV and Volume Control (VC) modes at 2 different levels of minute volume in 2 sets. ASV mode is expected to be safe measured by adequate inspiratory transpulmonary pressures and expected to be as effective as VC mode with lower intrinsic positive end expiratory pressure (iPEEP) levels.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Izmir, Yenisehir, 35550, Turkey (Türkiye)
Acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) may require mechanical ventilation. Various mechanical ventilation strategies and modes can be used to manage respiratory insufficiency in such patients. High tidal volumes required for mechanical ventilation of patients with obstructive pathologies is a well-known fact. Adapted Support Ventilation (ASV) is an intelligent closed-loop mechanical ventilation mode which automatically adjusts ventilation to lung mechanics. Led by measured lung mechanics, ASV mode often generates higher than usual tidal volumes during mechanical ventilation of COPD patients, particularly if the minute volume (MV) target is high. Thus, the effects of high tidal volumes on inspiratory transpulmonary pressure (Ptp), and whether Ptp stays within safe limits during ASV mode is of great interest.
Patients with acute exacerbation of COPD who required mechanical ventilation will be enrolled in the first 24 hours of admission to the intensive care unit. All patients will be deeply sedated. An esophageal balloon catheter will be inserted in order to measure transpulmonary pressure. 100 % minute volume target will be calculated in advance as 100 ml per ideal body weight.
Patients will be ventilated with two different MV targets in two sets. 'Adapted support ventilation' and 'volume control (VC)' modes will be used consecutively within each set. While the target minute volume will be 100 % in the first set, the volume target in the second set will be tuned to decrease patients PaCO2 below 45 mmHg. The sequence of ventilation mode will be randomized within each set. Ventilation periods will be 30 minutes with 15 minutes washout period in between. İf Ptp increase above 20 cmH20 at any ventilation mode, the tidal volume will be decreased.
ASV mode is expected to be safe, assessed by adequate inspiratory transpulmonary pressures, and expected to be as effective as VC mode with lower intrinsic positive end expiratory pressure (iPEEP) levels.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be ventilated to reach minute volume target of %100 (100 ml per ideal body weight).
Patients will be ventilated to reach minute volume target associated with PaCO2 less than 45%.
Time frame: 30'th minute of each intervention arm
Ptpinsp will be measured with an inspiratory pause maneuver.
Time frame: 30'th minute of each intervention arm
PEEPi will be measured with an expiratory hold maneuver.
Time frame: 30'th minute of each intervention arm
Mean arterial pressure measured by invasive or non-invasive methods
Time frame: 30'th minute of each intervention arm
Ratio of arterial partial oxygen pressure to inspired fraction of oxygen
Time frame: 30'th minute of each intervention arm
Heart rate measured by ECG
Contact information is provided by the study sponsor or research team.
Burcu Acar Cinleti, MD
CONTACT
Sami C Kirakli, MD
CONTACT
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Other
Does Automatically Generated Tidal Volumes With Closed-loop Ventilation Leads to Safe Transpulmonary Pressures in Intubated Chronic Obstructive Pulmonary Disease Patients?
Acronym: COPD-SAFE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04231760
Chronic Disease, Chronic Obstructive Pulmonary Disease
View Trial DetailsNCT07656142
Chronic Disease, Chronic Obstructive Pulmonary Disease
View Trial DetailsNCT05351242
Asthma, Bronchial Diseases
Hellerup, Capital Region, Denmark
View Trial DetailsNCT07633314
Chronic Disease, Chronic Obstructive Pulmonary Disease
Yulin, Guangxi, China
View Trial Details